What is ELAN's market cap?

$12.65B, based on the Nov 4 close of $25.31.

Does Elanco Animal Health Incorporated pay a dividend?

No regular cash dividend has been paid in the last year.

How much of ELAN is sold short?

31.1M shares, 6.3% of float, as of Oct 15, 2026.

What sector is ELAN in?

Healthcare, in the Pharmaceuticals industry.

NYSE · ELANHealthcarePharmaceuticals

Elanco Animal Health Incorporated Common Stock (ELAN)

$25.31+3.01%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$25.29▲ 10.68% in range

Nov 3, 2025Low $19.80 · High $26.84Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Elanco Animal Health Incorporated closed at $25.31 on Nov 4, up 3.01%, 5.7% below its 52-week closing high. Volume of 7.7M shares was 1.64× its 20-day average (above normal).

Split-adjusted performance: +12.6% over one month, -3.3% over six months, +10.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.37B, up 10.2% from a year earlier, with a net margin of 3.9%.

Short interest was 31.1M shares at the Oct 15 settlement, down 16.6% from the prior report (6.3% of float, 6.4 days to cover).

Market cap$12.65B499.6M shares

Revenue · quarter$1.37B+10.2% YoY

Diluted EPS$0.11+450.0% YoY

P/E · TTM—P/S 2.5×

Net margin3.9%Gross 58.3%

Dividend yieldNone

52-week range19.80 – 26.84−5.7% from high

Volume7.7M1.64× 20-day avg

Volatility · 60d30.7%Annualised

Short % of float6.3%6.4 days to cover

Net cash-$3.39BCash $530.0M

Next earnings—Not scheduled

Split-adjusted performance

1W +11.7%1M +12.6%3M +4.6%6M −3.3%YTD +11.8%1Y +10.8%3Y +187.3%5Y −24.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum69

Revenue growth56

Net margin74

Value (low P/E)—

Size95

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short31.1M−16.6% vs prior

Days to cover6.4Settled Oct 15

% of float6.3%

Short vol. 10d46.5%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
ELANElanco Animal Health Incorporated	$25.31	+3.01%	−3.3%	+10.2%	3.9%	—	$12.65B
SMMTSummit Therapeutics	$16.17	+2.34%	−9.4%	—	—	—	$12.90B	Compare
BMRNBioMarin Pharmaceuticals	$57.13	+2.64%	+4.6%	+19.9%	4.5%	151.5	$11.06B	Compare
BBIOBridgeBio Pharma	$77.89	+5.21%	+14.4%	+192.6%	−23.5%	—	$15.17B	Compare
JAZZJazz Pharmaceuticals	$234.66	+2.14%	+2.7%	+10.4%	−38.9%	74.0	$15.23B	Compare
TGTXTG Therapeutics	$61.63	+1.45%	+46.8%	+70.3%	3.2%	21.4	$9.43B	Compare
PTGXProtagonist Therapeutics	$143.37	+2.23%	+37.9%	+3749.2%	76.3%	111.9	$9.28B	Compare
SYRESpyre Therapeutics	$99.04	−0.23%	+35.7%	—	—	—	$9.26B	Compare
MDGLMadrigal Pharmaceuticals	$400.43	+1.04%	−25.8%	+50.1%	12.9%	—	$9.25B	Compare

News about Elanco Animal Health Incorporated

All news →

Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · Oct 19, 2026▲ Positive Elanco Director Purchases 40,000 Shares for $936,000The Motley Fool · Sep 4, 2026▲ Positive Elanco Animal Health Moves Higher On Earnings Strength And Product MomentumBenzinga · May 6, 2026▲ Positive

Quick answers

What does Elanco Animal Health Incorporated do?: Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020.
What is ELAN's market cap?: $12.65B, based on the Nov 4 close of $25.31.
Does Elanco Animal Health Incorporated pay a dividend?: No regular cash dividend has been paid in the last year.
How much of ELAN is sold short?: 31.1M shares, 6.3% of float, as of Oct 15, 2026.
What sector is ELAN in?: Healthcare, in the Pharmaceuticals industry.

About Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

HQ: Indianapolis, IN9,900 employeesListed Sep 20, 2018elanco.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology